Triple negative breast cancer: special histological types and emerging therapeutic methods
2020 · Cancer Biology and Medicine · 77 citations
https://doi.org/10.20892/j.issn.2095-3941.2019.0465
L
Lu Cao
Ruijin Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
493
Citations
12
h-index
13
i10-index
Lu Cao is an academic researcher from Ruijin Hospital. The author has contributed to research in topics: Estrogen and related hormone effects & Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research. The author has an h-index of 12, co-authored 17 publications.
ORCID: 0000-0001-9307-5092Papers by this author
worksAndrogen receptor and heat shock protein 27 co-regulate the malignant potential of molecular apocrine breast cancer
2018 · Journal of Experimental & Clinical Cancer Research · 45 citations
https://doi.org/10.1186/s13046-018-0762-y
TGF-β1 stimulates epithelial–mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer
2019 · Cancer Cell International · 39 citations
https://doi.org/10.1186/s12935-019-1068-7
Additional file 5 of ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.23084055
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat